John C Jacobs Harmony Biosciences Holdings, Inc. (HRMY) insider trading activity

HRMY Quotes by TradingView

John C Jacobs is PRESIDENT, CEO of Harmony Biosciences Holdings, Inc.. Currently has a direct ownership of 0 shares of HRMY, which is worth approximately $0. The most recent transaction as insider was on Aug 15, 2022, when has been sold 40,000 shares (Common Stock) at a price of $51.4 per share, resulting in proceeds of $2,056,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

John C Jacobs Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2022
SELL
Open market or private sale
$2,056,000 $51.4 p/Share
40,000 Reduced 100.0%
0 Common Stock
Aug 15 2022
BUY
Exercise of conversion of derivative security
$328,800 $8.22 p/Share
40,000 Added 50.0%
40,000 Common Stock
Jun 15 2022
SELL
Open market or private sale
$686,400 $45.76 p/Share
15,000 Reduced 100.0%
0 Common Stock
Jun 15 2022
BUY
Exercise of conversion of derivative security
$123,300 $8.22 p/Share
15,000 Added 50.0%
15,000 Common Stock
Jun 13 2022
SELL
Open market or private sale
$1,102,000 $44.08 p/Share
25,000 Reduced 100.0%
0 Common Stock
Jun 13 2022
BUY
Exercise of conversion of derivative security
$205,500 $8.22 p/Share
25,000 Added 50.0%
25,000 Common Stock
Mar 16 2022
SELL
Open market or private sale
$679,800 $45.32 p/Share
15,000 Reduced 100.0%
0 Common Stock
Mar 16 2022
BUY
Exercise of conversion of derivative security
$123,300 $8.22 p/Share
15,000 Added 50.0%
15,000 Common Stock
Mar 14 2022
SELL
Open market or private sale
$1,068,250 $42.73 p/Share
25,000 Reduced 100.0%
0 Common Stock
Mar 14 2022
BUY
Exercise of conversion of derivative security
$205,500 $8.22 p/Share
25,000 Added 50.0%
25,000 Common Stock
Jan 04 2022
SELL
Open market or private sale
$815,093 $45.15 p/Share
18,053 Reduced 100.0%
0 Common Stock
Jan 04 2022
BUY
Exercise of conversion of derivative security
$148,396 $8.22 p/Share
18,053 Added 50.0%
18,053 Common Stock
Jan 03 2022
SELL
Open market or private sale
$480,925 $45.17 p/Share
10,647 Reduced 100.0%
0 Common Stock
Jan 03 2022
BUY
Exercise of conversion of derivative security
$87,518 $8.22 p/Share
10,647 Added 50.0%
10,647 Common Stock
Dec 27 2021
SELL
Open market or private sale
$58,539 $45.03 p/Share
1,300 Reduced 100.0%
0 Common Stock
Dec 27 2021
BUY
Exercise of conversion of derivative security
$10,686 $8.22 p/Share
1,300 Added 50.0%
1,300 Common Stock
Dec 13 2021
SELL
Open market or private sale
$955,750 $38.23 p/Share
25,000 Reduced 100.0%
0 Common Stock
Dec 13 2021
BUY
Exercise of conversion of derivative security
$205,500 $8.22 p/Share
25,000 Added 50.0%
25,000 Common Stock
Sep 13 2021
SELL
Open market or private sale
$898,250 $35.93 p/Share
25,000 Reduced 100.0%
0 Common Stock
Sep 13 2021
BUY
Exercise of conversion of derivative security
$205,500 $8.22 p/Share
25,000 Added 50.0%
25,000 Common Stock

Also insider at

NVAX
NOVAVAX INC Healthcare
President and CEO
JCJ

John C Jacobs

PRESIDENT, CEO
Plymouth Meeting, PA

Track Institutional and Insider Activities on HRMY

Follow Harmony Biosciences Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRMY shares.

Notify only if

Insider Trading

Get notified when an Harmony Biosciences Holdings, Inc. insider buys or sells HRMY shares.

Notify only if

News

Receive news related to Harmony Biosciences Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HRMY